Godrej Agrovet (GODREJAGRO) Q3 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 25/26 earnings summary
8 Jul, 2026Executive summary
Q3 FY26 saw consolidated revenues grow 11% year-over-year to ₹2,718 crore, with profit before tax up 23% and EBITDA growth of 25%, driven by margin expansion, operational efficiencies, and strong segment contributions.
Nine-month consolidated revenues reached ₹7,900 crore, up 9% year-over-year; profit before tax (excluding exceptional items) rose 17% to ₹482 crore.
Unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, were approved, with limited review reports carrying unmodified opinions.
Financial statements prepared in accordance with Ind-AS and reviewed by statutory auditors.
Animal Feed and Vegetable Oil segments delivered robust volume and margin growth, while Dairy and Crop Protection faced headwinds from higher input costs and adverse weather.
Financial highlights
Q3 FY26 consolidated revenue was ₹2,718 crore, up 11% year-over-year; EBITDA was ₹260 crore, up 13.6%; PBT before non-recurring items was ₹169 crore, up 23.1%.
PAT before non-recurring items grew 33.9% to ₹133 crore; EBITDA margin improved to 9.6%.
For 9M FY26, revenue rose 9% to ₹7,900 crore, EBITDA up 8.9% to ₹763 crore, and PBT up 13.2% to ₹482 crore.
Animal Feed segment volumes up 12% year-over-year in Q3; cattle feed volumes surged 21%.
Vegetable Oil segment revenue up 27% year-over-year, with segment results up 25%.
Outlook and guidance
Astec LifeSciences targets 15% revenue growth in FY27, with CDMO expected to lead growth and margins to improve as demand stabilizes.
Crop Protection expects healthy growth ex-co-marketing impact in Q4, with new product launches and diversification underway.
Oil Palm business expects FFB tonnage growth in the 12%-15% CAGR range, supported by acreage expansion and demographic dividend.
Foods business to focus on branded retail, aiming for continued margin expansion and innovation.
Continued focus on margin expansion, operational efficiency, and new product development is expected to drive future growth.
Latest events from Godrej Agrovet
- Revenue and PAT grew, but El Niño, inflation and negative H1 operating cash flow pressured performance.GODREJAGRO
Q2 26/27 - Sales grew and leverage eased, but lower consolidated PAT and an audit qualification temper the FY18 story.GODREJAGRO
Q4 17/18 - Revenue expanded and leverage fell, but ESOP-linked remuneration triggered a qualified audit opinion.GODREJAGRO
Q4 16/17 - Revenue grew, margins faced input-cost pressure, and acquisitions lifted reported profit.GODREJAGRO
Q4 18/19 - Higher income was offset by poultry losses, COVID disruption and weaker consolidated profit.GODREJAGRO
Q4 19/20 - Profit rose despite weaker sales as feed and subsidiaries offset COVID disruption.GODREJAGRO
Q4 20/21 - Record FY22 income, led by Feed and Oil Palm, offset by crop and food margin pressure.GODREJAGRO
Q4 21/22 - Revenue grew 13%, while margin pressure cut PAT; cash generation and growth investment strengthened.GODREJAGRO
Q4 22/23 - Q1 FY27 revenue up 10% to ₹2,855.22 crore, but margins fell and new CFO appointed.GODREJAGRO
Q1 26/27